Graham Corp (GHM) Q2 2027 Earnings Call Transcript

Graham Corporation reported fiscal Q2 2027 revenue of $69.8 million, up 6%, while adjusted EBITDA rose 64% to $10.3 million and gross margin expanded 650 bps to 28.2%. Backlog reached a record $561.3 million, up 12% year over year, with 83% attributed to defense; space revenue increased 59%, while energy and process revenue fell 17%. The company reaffirmed FY2027 revenue guidance of $285 million-$295 million and adjusted EBITDA guidance of $35 million-$40 million, and raised its gross margin outlook to 25.0%-26.0% from 24.5%-25.5%.

Analysis

GHM’s key earnings signal is improving conversion economics, not the quarter’s peak gross margin. Management explicitly expects margins to normalize from 28.2% as unusually low prior-year material receipts roll out; the higher full-year range is a better test of whether execution and mix gains are durable. Near term, holiday-related labor seasonality and lumpy customer receipts can obscure underlying progress. Over 1–3 months, watch whether orders translate into shipments without renewed margin slippage. The backlog is unusually defense-heavy, and its stated funding status reduces—but does not eliminate—appropriation, schedule, and customer-concentration risk. Multi-year naval programs help visibility, while the second-order constraint is GHM’s own throughput: building capacity ahead of conversion protects future growth but raises utilization and return-on-capital risk if program timing slips.

Space’s strong bookings offer upside beyond naval exposure, but orders are not revenue; qualification, production ramps, and launch-customer schedules remain conversion gates. Energy/process weakness is a counterweight and limits how broadly the defense/space growth thesis should be extrapolated. Reported cash generation is also partly working-capital timing, so do not capitalize one half-year’s cash flow as a run rate. Over 6–18 months, the bull case depends on sustained organic growth and margin delivery, not acquisition contribution alone. Without valuation or market-reaction data, the results support a constructive watch/entry-on-weakness stance, not an unconditional chase. Falsifiers: backlog conversion or book-to-bill weakening, gross margin falling below the raised outlook, or delayed capacity utilization.

Key Decisions for Investors

• Constructive on GHM, but avoid chasing the earnings move without valuation context; consider initiating or adding on post-event weakness if the operating thesis remains intact.
• For the next 1–3 months, track quarterly orders/book-to-bill, defense and space backlog conversion, and gross margin against the 25%–26% full-year outlook. Treat a miss driven by execution—not merely seasonality—as a thesis warning.
• Over 6–18 months, monitor Arvada capacity utilization and returns on expansion spending. Delayed program ramps or persistently low utilization would challenge the growth case and the company’s stated capital-return discipline.
• Do not extrapolate first-half operating cash flow; verify that collections and customer deposits normalize while energy/process demand and FlackTek’s production-scale orders develop.